Publicacions
-
Ibañez-Toda L and de Zegher F.
Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in non-obese adolescents and women
HUMAN REPRODUCTION UPDATE . 12(3): 243-252. Nº de cites: 82
-
Petry CJ, Ong KK, Michelmore KF, Artigas S, Wingate DL, Balen AH, de Zegher F, Ibañez-Toda L and Dunger DB.
Associations between common variation in the aromatase gene promoter region and testosterone concentrations in two young female populations
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY . 98(4-5): 199-206. Nº de cites: 15
-
Ibañez-Toda L, Valls C and de Zegher F.
Discontinuous low-dose flutamide-metformin plus an oral or a transdermal contraceptive in patients with hyperinsulinaemic hyperandrogenism:: normalizing effects on CRP, TNF-a and the neutrophil/lymphocyte ratio
HUMAN REPRODUCTION . 21(2): 451-456. Nº de cites: 25
-
Casano-Sancho P, López-Bermejo A, Fernández-Real JM, Monrós E, Valls C, Rodríguez-González FX, Ricart W and Ibañez-Toda L.
The tumour necrosis factor (TNF)-a-308GA promoter polymorphism is related to prenatal growth and postnatal insulin resistance
CLINICAL ENDOCRINOLOGY . 64(2): 129-135. Nº de cites: 11
-
Pineda M, Ormazabal-Herrero A, López-Gallardo E, Nascimento-Osorio A, Solano A, Herrero MD, Vilaseca MA, Briones P, Ibañez-Toda L, Montoya J and Artuch-Iriberri R.
Cerebral folate deficiency and leukoencephalopathy caused by a mitochondrial DNA deletion
ANNALS OF NEUROLOGY . 59(2): 394-398. Nº de cites: 92
-
Ibañez-Toda L, Jaramillo A, Ferrer A and De Zegher F.
Absence of hepatotoxicity after long-term, low-dose flutamide in hyperandrogenic girls and young women
Obstetrical and Gynecological Survey . 61(1): 33-34.
-
Ibañez-Toda L, Valls C and De Zegher F.
Discontinuous low-dose flutamide-metformin plus an oral or a transdermal contraceptive in patients with hyperinsulinaemic hyperandrogenism: Normalizing effects on CRP, TNF-a and the neutrophil/lymphocyte ratio
Obstetrical and Gynecological Survey . 61(8): 520-521.
-
Carel, JC, Blumberg, J, Seymour, C, Adamsbaum, C and Lahlou, N.
Three-month sustained-release triptorelin (11.25 mg) in the treatment of central precocious puberty
EUROPEAN JOURNAL OF ENDOCRINOLOGY . 154(1): 119-124. Nº de cites: 48
-
Ibañez-Toda L and de Zegher F.
Puberty after prenatal growth restraint
Hormone Research . 65: 112-115. Nº de cites: 51
-
de Zegher F, Ong KK, Ibañez-Toda L and Dunger DB.
Growth hormone therapy in short children born small for gestational age
Hormone Research . 65: 145-152. Nº de cites: 28